Recent Company News

• 10:08 AM ET Oct 03, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (187 total)

• 04:20 AM ET Oct 02, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (99 total)

• 08:36 AM ET Oct 01, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:58 AM ET Oct 01, 2025
  

  Healthcare, basic resources, energy the best performers; tech, industrials and construction main laggards:

• 04:40 AM ET Oct 01, 2025
  

  European healthcare boosted by easing regulatory uncertainty following Pfizer-US deal:

• 04:38 AM ET Oct 01, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:54 AM ET Oct 01, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:47 AM ET Oct 01, 2025
  

  StreetAccount Sector Summary: Healthcare Monthly Recap - September 2025

• 05:42 PM ET Sep 30, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:18 PM ET Sep 30, 2025
  

  Novartis issues press release regarding FDA approval for Rhapsido (remibrutinib) (CHF 100.12, 0.00)